Quick Answer
Guardant Health, Inc. reported Total Revenue of $982.02 million for the year ending 2025.
- Guardant Health, Inc. showed an increase of +32.9% in Total Revenue from 2024 to 2025.
- This data is from Guardant Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $11.13 million | Q1 2018: $16.69 million | Q2 2018: $19.38 million | Q3 2018: $21.69 million | Q1 2019: $36.66 million | Q2 2019: $53.98 million | Q3 2019: $60.85 million | Q1 2020: $67.51 million | Q2 2020: $66.34 million | Q3 2020: $74.57 million | Q1 2021: $78.67 million | Q2 2021: $92.10 million | Q3 2021: $94.78 million | Q1 2022: $96.10 million | Q2 2022: $109.14 million | Q3 2022: $117.40 million | Q1 2023: $128.71 million | Q2 2023: $137.15 million | Q3 2023: $143.03 million | Q1 2024: $168.49 million | Q2 2024: $177.24 million | Q3 2024: $191.48 million | Q1 2025: $203.47 million | Q2 2025: $232.09 million | Q3 2025: $265.20 million.
- Over the full 10 years of available data (2016 to 2025), Guardant Health, Inc.'s Total Revenue has grown by 3,789.3%.
- Historical annual values: Fiscal year 2025: $982.02 million | Fiscal year 2024: $739.02 million | Fiscal year 2023: $563.95 million | Fiscal year 2022: $449.54 million | Fiscal year 2021: $373.65 million | Fiscal year 2020: $286.73 million | Fiscal year 2019: $214.38 million | Fiscal year 2018: $90.64 million | Fiscal year 2017: $49.84 million | Fiscal year 2016: $25.25 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: